Wordt geladen...
Pilot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects and quality-of-life
Therapeutic strategy remains unclear with no clear consensus for men with high-risk prostate cancer after radical prostatectomy. We aimed to evaluate into a prospective randomized trial the effectiveness and the feasibility of adjuvant weekly paclitaxel combined with androgen deprivation therapy (AD...
Bewaard in:
Hoofdauteurs: | , , , , , , , , , , |
---|---|
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
Nature Publishing Group
2010
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2891708/ https://ncbi.nlm.nih.gov/pubmed/19935771 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/pcan.2009.51 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|